Pro Medicus Ltd (ASX: PME) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Pro Medicus Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$6.08 billion
P/E Ratio
250.00
Dividend Yield
0.22%
Shares Outstanding
104.21 million
Earnings per share
0.235
Dividend per share
0.14
Year To Date Return
70.99%
Earnings Yield
0.40%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Pro Medicus Ltd (ASX: PME)
Latest News
Share Market News
These ASX 200 CEOs have the most wealth tied up in their companies
Share Market News
Why the Pro Medicus (ASX:PME) share price is up 3% in a week
Growth Shares
3 reasons why Pro Medicus (ASX:PME) is a top class share
ASX Shares
These ASX 200 shares are the most tightly held by individual insiders
52-Week Highs
Pro Medicus (ASX:PME) share price soars to all-time high
Technology Shares
How did the S&P/ASX All Technologies Index (XTX) perform in FY21?
Healthcare Shares
The 5 best ASX 200 healthcare shares of financial year 2021
Growth Shares
Are these 2 high-flying ASX shares buys?
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 04 Mar 2021 | $0.0700 | 100.00% | Interim | 19 Mar 2021 |
| 10 Sep 2020 | $0.0600 | 100.00% | Final | 02 Oct 2020 |
| 05 Mar 2020 | $0.0600 | 100.00% | Interim | 20 Mar 2020 |
| 12 Sep 2019 | $0.0450 | 100.00% | Final | 04 Oct 2019 |
| 12 Mar 2019 | $0.0250 | 100.00% | Special Cash | 17 May 2019 |
| 07 Mar 2019 | $0.0350 | 100.00% | Interim | 22 Mar 2019 |
| 06 Sep 2018 | $0.0350 | 100.00% | Final | 27 Sep 2018 |
| 08 Mar 2018 | $0.0250 | 100.00% | Interim | 23 Mar 2018 |
| 07 Sep 2017 | $0.0250 | 100.00% | Final | 28 Sep 2017 |
| 08 Sep 2016 | $0.0150 | 0.00% | Final | 29 Sep 2016 |
| 10 Mar 2016 | $0.0150 | 0.00% | Interim | 24 Mar 2016 |
| 09 Sep 2015 | $0.0100 | 0.00% | 02 Oct 2015 | |
| 04 Mar 2015 | $0.0100 | 0.00% | 20 Mar 2015 | |
| 10 Sep 2014 | $0.0100 | 100.00% | 03 Oct 2014 |
PME ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Pro Medicus Ltd
Pro Medicus Limited (ASX: PME) provides healthcare imaging software and services to hospitals, diagnostic imaging groups and other health related entities in Australia, North America and Europe.
The company is a leading provider of radiology information systems (RIS), picture archiving and communication systems (PACS) and advanced visualisation solutions across the globe. It has more than 30 years’ experience in helping clients deliver first-rate patient care by enhancing and streamlining medical practice management.
Primary products for RIS include medical accounting, clinical reporting, appointments/scheduling and marketing/ management information applications.
After explosive growth in 2019, the Pro Medicus share price has been able to successfully navigate the impacts of COVID-19 in 2020.
PME Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 23 Jul 2021 | $58.34 | $0.50 | 0.86% | 97,527 | $57.79 | $58.34 | $57.42 |
| 22 Jul 2021 | $57.84 | $-0.33 | -0.57% | 132,783 | $58.50 | $58.82 | $57.18 |
| 21 Jul 2021 | $58.17 | $-1.30 | -2.19% | 121,756 | $59.58 | $59.91 | $58.02 |
| 20 Jul 2021 | $59.47 | $0.57 | 0.97% | 214,959 | $58.90 | $60.55 | $58.82 |
| 19 Jul 2021 | $58.90 | $-0.10 | -0.17% | 111,370 | $59.06 | $59.74 | $58.80 |
| 16 Jul 2021 | $59.00 | $0.75 | 1.29% | 137,449 | $57.74 | $59.04 | $57.65 |
| 15 Jul 2021 | $58.25 | $0.27 | 0.47% | 204,333 | $57.52 | $58.67 | $57.15 |
| 14 Jul 2021 | $57.98 | $-1.22 | -2.06% | 165,336 | $59.09 | $59.70 | $57.59 |
| 13 Jul 2021 | $59.20 | $1.72 | 2.99% | 183,373 | $58.10 | $59.90 | $57.83 |
| 12 Jul 2021 | $57.48 | $1.25 | 2.22% | 116,472 | $56.10 | $57.79 | $55.87 |
| 09 Jul 2021 | $56.23 | $-1.05 | -1.83% | 174,349 | $57.27 | $57.27 | $55.85 |
| 08 Jul 2021 | $57.28 | $-0.18 | -0.31% | 156,385 | $57.61 | $58.17 | $56.93 |
| 07 Jul 2021 | $57.46 | $2.24 | 4.06% | 128,540 | $56.00 | $57.81 | $55.69 |
| 06 Jul 2021 | $55.22 | $-0.98 | -1.74% | 125,248 | $56.01 | $56.70 | $55.00 |
| 05 Jul 2021 | $56.20 | $-0.47 | -0.83% | 153,360 | $56.67 | $57.20 | $55.88 |
| 02 Jul 2021 | $56.67 | $-0.21 | -0.37% | 117,117 | $57.03 | $57.38 | $56.09 |
| 01 Jul 2021 | $56.88 | $-1.84 | -3.13% | 212,819 | $58.10 | $58.23 | $56.68 |
| 30 Jun 2021 | $58.72 | $0.81 | 1.40% | 197,742 | $58.50 | $59.22 | $57.80 |
| 29 Jun 2021 | $57.91 | $0.91 | 1.60% | 177,491 | $56.99 | $58.12 | $56.40 |
| 28 Jun 2021 | $57.00 | $0.12 | 0.21% | 155,833 | $57.04 | $57.05 | $56.33 |
| 25 Jun 2021 | $56.88 | $0.01 | 0.02% | 208,021 | $57.10 | $57.54 | $56.40 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 18 Feb 2021 | Sam Hupert | Sell | 1 | $45,970,000 |
On-market trade.
|
| 18 Feb 2021 | Anthony Hall | Sell | 1 | $45,970,000 |
On-market trade.
|
| 21 Aug 2020 | Deena Shiff | Buy | 1 | $49,998 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr Sam Aaron Hupert | Chief Executive OfficerManaging Director | Oct 2007 |
Dr Hupert commenced General Practice in 1980. Realising the potential for computers in medicine he left general practice in late 1984 to devote himself to managing the Group.
|
| Mr Anthony Barry Hall | Executive DirectorTechnology Director | Jan 1983 |
Mr Hall has been principal architect and developer of the core software systems. His current focus is the transition to and development of the Company's next generation RIS systems.
|
| Mr Peter Terence Kempen | Non-Executive ChairmanNon-Executive Director | Mar 2008 |
Mr Kempen is Chairman of Australasian Leukaemia and Lymphoma Group and Chairman of LogieSmith Lanyon. He is also a Trustee of the Barr Family Foundation and a Member of the Board of St Hilda's College Ltd, University of Melbourne. He has previously been Chairman of Patties Food Limited, Danks Holdings Limited, Ivanhoe Grammar School and Managing Partner of Ernst & Young Corporate Finance Australia.
|
| Ms Deena Robyn Shiff | Non-Executive Director | Aug 2020 |
Ms Shiff has had a senior legal career followed by a senior executive career in Australian telecommunications. Her subsequent board career as a Chairman/Non-Executive Director, has included a number of boards of global infrastructure and ICT companies. Deena was the first woman Group Managing Director at Telstra running Telstra Wholesale and establishing and running Telstra Business, a division focused on the SME market. In 2011 Deena established Telstra's corporate venture capital arm, Telstra Ventures before leaving in 2013 to focus on a full time Board career. Deena is currently Chair of Marley Spoon AG and a Non-Executive Director of Appen Ltd, both of which are listed on the ASX. She also holds a number of positions on Government and Not for Profit Boards.
|
| Mr Anthony James Glenning | Non-Executive Director | May 2016 |
Mr Glenning is the fund manager of Skalata Ventures. He is Chairman of Cyrise Pty Ltd. He has previously been Investment Director of Starfish Ventures and was the founder and previously the CEO of Tonic Systems and a founder & Non-Executive Director of Cameron Systems.
|
| Dr Leigh Bernard Farrell | Non-Executive Director | Sep 2017 |
Mr Farrell is Executive Director of AdNED Pty Ltd and was previously Vice President, Commercial of Certara USA, Inc. Prior to this, he was Chairman and COO of d3 Medicine LLC.
|
| Mr Clayton James Hatch | Chief Financial OfficerCompany Secretary | Jul 2009 |
-
|
| Clayton James Hatch | Chief Financial OfficerCompany Secretary |
-
|
|
| Danny Tauber | General Manager - Pro Medicus Limited |
-
|
|
| Brad Levin | General Manager - Visage Imaging Inc |
-
|
|
| Sean Lambright | Global Head of Sales - Visage Imaging Inc. |
-
|
|
| Malte Westerhoff | Managing Director - Visage Imaging GmbH |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Dr S Hupert | 28,137,660 | 27.07% |
| Mr A Hall | 28,109,000 | 27.04% |
| Hsbc Custody Nominees (Australia) Limited | 11,618,835 | 11.18% |
| J P Morgan Nominees Australia Limited | 5,458,034 | 5.25% |
| Citicorp Nominees Pty Ltd | 3,268,267 | 3.14% |
| National Nominees Limited | 1,423,797 | 1.37% |
| HSBC Custody Nominees (Australia) Limited Gsco Eca | 1,258,057 | 1.21% |
| BNP Paribas Noms Pty Ltd | 1,009,441 | 0.97% |
| BNP Parabis Nominees Pty Ltd | 857,364 | 0.82% |
| Mr Bram Vander Jagt & Mrs Maaike Vander Jagt | 700,000 | 0.67% |
| Mr Peter Terence Kempen & Mrs Elaine Margaret Kempen | 678,082 | 0.65% |
| Grain Exporters (Australia) Pty Ltd | 585,668 | 0.56% |
| Mr Danny Tauber | 380,915 | 0.37% |
| Mr Kenneth John Vander Jagt & Mrs Tanya Vander Jagt | 364,020 | 0.35% |
| Mr Roderick Lyle | 340,000 | 0.33% |
| Mr Stephen Geoffrey Wilson & Ms Denise Adele Prandi | 300,037 | 0.29% |
| Mr Evan Philip Clucas and Ms Leanne Jane Weston | 287,980 | 0.28% |
| Mr Colin Gregory Organ | 271,000 | 0.26% |
| Mr John Charles Plummer | 250,000 | 0.24% |
| Mr Michael Wu | 239,942 | 0.23% |
Frequently Asked Questions
-
Pro Medicus is a leading imaging IT provider that provides radiology IT software and services to hospitals, imaging centers and health care groups worldwide.
-
PME’s most recent dividend payment was made to shareholders March 20, with the distribution amount being $0.06.